Yahoo Finance Insider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
On May 7, 2024, Edward Basile, Director at TransMedics Group Inc (NASDAQ:TMDX), sold 7,157 shares of the company. The transaction was filed on the same day with the SEC.
TransMedics Group Inc is a medical technology company focused on developing products that improve the viability and functionality of organs for transplant. The company's innovative Organ Care System (OCS) allows for organs to be kept in a near-physiologic state during transport, potentially increasing the success rate of transplants.
Following this transaction, the insider's total sales over the past year amount to 14,314 shares, with no recorded purchases. This sale is part of a broader trend observed at TransMedics Group Inc, where there have been 38 insider sells and only 1 insider buy over the past year.
Shares of TransMedics Group Inc were priced at $129.98 on the day of the sale, bringing the company's market cap to approximately $4.19 billion.
The stock's valuation metrics, including the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, contribute to the GF Value of $206.15. With the current stock price, TransMedics Group Inc has a price-to-GF-Value ratio of 0.63, indicating that the stock might be a possible value trap, and investors should think twice before investing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
